Goldenwell Biotech, Inc. (GWLL)
OTCMKTS
· Delayed Price · Currency is USD
3.000
+0.990 (49.25%)
At close: Nov 17, 2025
Goldenwell Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 0.08 | 0.05 | 0.05 | 0.05 | 0.21 | 0.25 | Upgrade
|
| Cash & Short-Term Investments | 0.08 | 0.05 | 0.05 | 0.05 | 0.21 | 0.25 | Upgrade
|
| Cash Growth | 197.46% | -7.19% | 15.73% | -78.46% | -14.09% | 0.80% | Upgrade
|
| Inventory | 0.17 | 0.17 | 0.17 | 0.18 | 0.2 | - | Upgrade
|
| Total Current Assets | 0.25 | 0.22 | 0.23 | 0.22 | 0.41 | 0.25 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0.03 | 0.05 | - | Upgrade
|
| Total Assets | 0.25 | 0.22 | 0.23 | 0.25 | 0.46 | 0.25 | Upgrade
|
| Accounts Payable | - | - | - | - | 0.11 | - | Upgrade
|
| Current Portion of Leases | - | - | - | 0.03 | 0.05 | - | Upgrade
|
| Current Unearned Revenue | 0.06 | 0 | 0 | 0 | - | - | Upgrade
|
| Total Current Liabilities | 0.06 | 0 | 0 | 0.03 | 0.16 | - | Upgrade
|
| Long-Term Debt | 0.27 | 0.27 | 0.14 | 0.02 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | -0 | - | Upgrade
|
| Total Liabilities | 0.34 | 0.27 | 0.14 | 0.05 | 0.16 | - | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1.3 | 1.3 | 1.3 | 1.3 | 0.42 | 0.33 | Upgrade
|
| Retained Earnings | -1.4 | -1.36 | -1.23 | -1.11 | -0.13 | -0.01 | Upgrade
|
| Comprehensive Income & Other | -0 | - | - | - | -0 | -0.08 | Upgrade
|
| Shareholders' Equity | -0.09 | -0.05 | 0.08 | 0.2 | 0.3 | 0.25 | Upgrade
|
| Total Liabilities & Equity | 0.25 | 0.22 | 0.23 | 0.25 | 0.46 | 0.25 | Upgrade
|
| Total Debt | 0.27 | 0.27 | 0.14 | 0.05 | 0.05 | - | Upgrade
|
| Net Cash (Debt) | -0.2 | -0.22 | -0.09 | 0 | 0.17 | 0.25 | Upgrade
|
| Net Cash Growth | - | - | - | -99.62% | -33.31% | 0.80% | Upgrade
|
| Net Cash Per Share | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 99 | 99 | 99 | 99 | 96 | 96 | Upgrade
|
| Total Common Shares Outstanding | 99 | 99 | 99 | 99 | 96 | 91.5 | Upgrade
|
| Working Capital | 0.19 | 0.22 | 0.23 | 0.2 | 0.25 | 0.25 | Upgrade
|
| Book Value Per Share | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Tangible Book Value | -0.09 | -0.05 | 0.08 | 0.2 | 0.3 | 0.25 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.